Hepatitis C Virus (HCV) by Quantitative NAAT
Also known as: HEPC QNT
Use
This test is intended for use as an aid in the diagnosis of HCV infection in individuals with antibody evidence of HCV and evidence of liver disease, individuals suspected to be actively infected with HCV, and those at risk for HCV infection with antibodies to HCV. Detection of HCV RNA indicates active infection. This test is also used in managing patients undergoing antiviral therapy, helping measure HCV RNA levels to determine sustained or nonsustained viral response.
Special Instructions
Not provided.
Limitations
A result of 'Not Detected' does not rule out the presence of inhibitors in the patient specimen or hepatitis C virus RNA concentrations below the detection level. This assay should not be used for blood donor screening, associated reentry protocols, or for screening human cells, tissues and cellular and tissue-based products (HCT/P). Interpret results within the context of all relevant clinical and laboratory findings.
FDA ApprovedNew York Approved
Methodology
PCR-based (qPCR)
Biomarkers
Hepatitis C Virus
Microorganism
LOINC Codes
- 11011-4 - HCV RNA SerPl NAA+probe-aCnc
- 38180-6 - HCV RNA SerPl NAA+probe-Log IU
- 11259-9 - HCV RNA SerPl Ql NAA+probe
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
2 mL
Minimum Volume
1.3 mL
Container
Lavender (EDTA), pink (K2EDTA), plasma preparation tube (PPT), or serum separator tube (SST)
Collection Instructions
Separate from cells within 24 hours of collection.
Storage Instructions
Ship frozen.
Causes for Rejection
Heparinized specimens
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 6 days |
| Frozen | 3 months |
Other tests from different labs that may be relevant